New Albany Molecular Research, Inc. (AMRI)'s CEO Ready To Make His Mark, Eyes Competitors

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Bill Marth is going shopping--and that says a lot about the turnaround happening at the company he runs, Albany Molecular Research Inc. At the start of this year, Marth and AMRI's co-founder Tom D'Ambra switched roles. Marth became president and CEO; D'Ambra became company chairman, the first time in AMRI's 23-year history that he isn't running the company. AMRI (Nasdaq: AMRI) is best-known for discovering the active ingredient in the allergy medication Allegra.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC